Health in Guinea-Bissau

1,274 indicators covering health for Guinea-Bissau.

IndicatorLatest Year10-yr change Rank
Domestic private health expenditure (PVT-D) per capita in US$ 52.75 2023 up 68.2% 134th
Domestic general government health expenditure (GGHE-D) per capita in 8.74 2023 up 142.1% 173rd
Total healthcare expenditure gdp 8.82 2023 up 25.3% 48th
Health expenditure government expenditure 4.29 2023 down 3.5% 177th
Mumps - number of reported cases 0 2025 110th
Proportion of health care facilities with no water service 22.2 2025 20th
Incidence of tuberculosis (per 100 000 population) 110 2023 down 25.7% 10th
Hib vaccine 68 2024 down 20.9% 170th
Congenital Rubella Syndrome - number of reported cases 0 2025 16th
External health expenditure (EXT) per capita in US$ 20.65 2023 up 86.3% 35th
Dentists 3 2024 down 57.1% 173rd
People with basic handwashing facilities including soap and water 15.7% 2024 up 137.7% 94th
Nursing and midwifery personnel 2,038 2024 up 130.3% 157th
Nursing personnel 1,837 2024 up 107.6% 155th
Number of new HIV infections per 1,000 uninfected population, by sex 0.4054 2024 down 61.5% 27th
People using safely managed drinking water services, rural 13.7% 2024 up 35.9% 69th
Raised blood pressure (SBP>=140 OR DBP>=90) 33.76 2019 down 10.4% 71st
Raised blood pressure (SBP>=140 OR DBP>=90) 30.04 2019 down 12.2% 97th
Hypertension: diagnosis coverage among adults aged 30-79 with 43.6% 2019 up 47.8% 145th
Hypertension among adults aged 30-79 years, prevalence 38 2019 down 4.5% 97th
Hypertension effective treatment coverage (controlled hypertension) 11.3% 2019 up 109.3% 140th
Hypertension: effective treatment coverage (controlled hypertension) 10.5% 2019 up 98.1% 143rd
Hypertension treatment coverage among adults aged 30-79 with 24.4% 2019 up 43.5% 151st
Hypertension treatment coverage among adults aged 30-79 with 26.7% 2019 up 46.7% 148th
Hypertension: diagnosis coverage among adults aged 30-79 with 40.9% 2019 up 46.6% 147th
Hypertension among adults aged 30-79 years, prevalence, crude 33.6 2019 down 6.9% 127th
Pneumococcal conjugate second or third-dose vaccines (PCVc) 90.0% 2025 up 800.0% 70th
People with basic handwashing facilities including soap and water 24.5% 2024 up 99.9% 105th
Adolescent birth rate 1.63 2017 down 84.9% 40th
Estimated number of malaria cases 242,430 Cases 2024 up 31.7% 43rd
Treatment success rate: previously treated TB cases 61 2020 up 13.0% 114th
Medical doctors 2.49 2024 up 25.8% 155th
Proportion of births attended by skilled health personnel 53.8% 2019 up 25.1% 145th
Prevalence of insufficient physical activity among adults aged 18+ 15.5% 2022 down 6.4% 151st
Prevalence of insufficient physical activity among adults aged 18+ 17.6% 2022 down 6.4% 146th
3.b.1 Proportion of surviving infants receiving 3 doses of 74 2022 down 14.9% 162nd
Nursing and midwifery personnel 9.26 2024 up 82.3% 161st
Estimated number of people (all ages) living with HIV 35,000 2025 down 5.4% 67th
Prevalence of HIV among adults aged 15 to 49 2.1% 2025 down 36.4% 17th
Cases of paralytic polio from wild vs vaccine derived viruses 0 2023 24th
Cases of paralytic polio from vaccine derived viruses 0 2023 24th
TB patients with known HIV status 93.0% 2024 up 40.9% 83rd
Reported number of people receiving antiretroviral therapy 28,856 2025 up 204.4% 65th
Estimated antiretroviral therapy coverage among people living with HIV 82.0% 2025 up 215.4% 44th
Dentists 0.01 2024 down 75.0% 172nd
Confirmed cases of RR-/MDR-TB 75 2024 up 200.0% 82nd
Hib3 number unvaccinated 15,688 2023 up 112.6% 87th
Number of new HIV infections 930 2025 down 51.1% 78th
Number of people dying from HIV-related causes 840 2025 down 55.8% 57th
Capital health expenditure 0.5% 2021 down 25.7% 30th
Adolescent birth rate 1.63 2017 down 84.9% 37th
Tested TB patients HIV-positive 27.0% 2024 down 27.0% 19th
Cause of death, by communicable diseases and maternal, prenatal and 59.1% 2021 down 9.5% 10th
Cause of death, by injury 8.0% 2021 up 15.6% 61st
Cause of death, by non-communicable diseases 30.8% 2021 up 11.0% 175th
Cause of death, by other COVID-19 pandemic-related outcomes 2.1% 2021 77th
Cause of death, by communicable diseases and maternal, prenatal and nu 88.6% 2021 down 3.6% 21st
Cause of death, by communicable diseases and maternal, prenatal and nu 89.2% 2021 down 2.3% 18th
Cause of death, by communicable diseases and maternal, prenatal and nu 88.9% 2021 down 2.8% 20th
Cause of death, by communicable diseases and maternal, prenatal and nu 60.3% 2021 down 8.5% 25th